Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Actavis Totowa Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for ACTAVIS TOTOWA, and what generic and branded alternatives to ACTAVIS TOTOWA drugs are available?

ACTAVIS TOTOWA has twenty-two approved drugs.

Summary for Actavis Totowa
US Patents:0
Patent Litigation for Actavis Totowa: See patent lawsuits for Actavis Totowa

Drugs and US Patents for Actavis Totowa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 078732-002 Feb 6, 2012 DISCN No No   Start Trial   Start Trial
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 074430-001 Feb 9, 1996 AB RX No No   Start Trial   Start Trial
Actavis Totowa REPAGLINIDE repaglinide TABLET;ORAL 090008-002 Jan 22, 2014 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.